Details of the Drug

General Information of Drug (ID: DM10C0L)

Drug Name
Picibanil
Synonyms Picivanil; OK-432; OK-PSA
Indication
Disease Entry ICD 11 Status REF
Carcinoma 2A00-2F9Z Phase 4 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C16H17N2O4S-
Canonical SMILES
CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C
InChI
InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/p-1/t11-,12+,14-/m1/s1
InChIKey
JGSARLDLIJGVTE-MBNYWOFBSA-M
Cross-matching ID
PubChem CID
640429
ChEBI ID
CHEMBL51354
CAS Number
54836-26-9
UNII
2F42BH7X2L
DrugBank ID
DB17591
TTD ID
D07HOF
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 ClinicalTrials.gov (NCT01699347) Cohort Prospective Study of Children With Head and Neck Cystic Malformation Who Are Treated With Intracystic OK432. U.S. National Institutes of Health.